Volume | 80,110 |
|
|||||
News | - | ||||||
Day High | 0.0022 | Low High |
|||||
Day Low | 0.0019 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Endonovo Therapeutics Inc (PK) | ENDV | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0019 | 0.0019 | 0.0022 | 0.002185 | 0.0025 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4 | 80,110 | $ 0.002192 | $ 176 | - | 0.001 - 0.0194 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
12:13:21 | 10 | $ 0.001735 | USD |
Endonovo Therapeutics Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
0 | 277.95M | 117.21M | 135k | -18.48M | -0.06 | 0.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Endonovo Therapeutics (PK) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ENDV Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0025 | 0.0027 | 0.0015 | 0.0026006 | 473,812 | -0.00032 | -12.60% |
1 Month | 0.0032 | 0.0036 | 0.0015 | 0.0026643 | 292,729 | -0.00102 | -31.72% |
3 Months | 0.00395 | 0.0058 | 0.0015 | 0.0028556 | 1,310,818 | -0.00177 | -44.68% |
6 Months | 0.011365 | 0.016 | 0.001 | 0.0040629 | 867,363 | -0.00918 | -80.77% |
1 Year | 0.0194 | 0.0194 | 0.001 | 0.0048714 | 499,038 | -0.01722 | -88.74% |
3 Years | 0.0339 | 0.06 | 0.001 | 0.0117246 | 353,788 | -0.03172 | -93.55% |
5 Years | 0.013 | 3.90 | 0.001 | 0.017733 | 1,079,949 | -0.01082 | -83.19% |
Endonovo Therapeutics (PK) Description
Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical Therapy for the treatment of inflammatory conditions, cardiovascular diseases and central nervous system disorders. Endonovo's Electroceutical Therapy is FDA-Cleared for the palliative treatment of pain and post-surgical edema (swelling) and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Endonovo's Electroceutical Therapy has CMS National Coverage for the treatment of chronic wounds. The Company's current pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders, including ischemic heart disease, acute concussions, post-concussion syndrome, traumatic brain injury (TBI) and multiple sclerosis. |